Shares of Hims & Hers Health Inc. (HIMS) surged 5.11% in Monday's pre-market session, following positive analyst coverage and raised price targets from Piper Sandler.
Analysts at Piper Sandler maintained a "Hold" rating on Hims & Hers Health but raised their price target on the stock from $21 to $24, reflecting potential growth opportunities for the company in the beauty and wellness sector.
While the firm highlighted interest rates, lending standards, and potential policies from the incoming administration as key factors to watch, it expressed optimism for U.S. beauty and wellness companies in 2025, positioning Hims & Hers Health as one of its top ideas for the year.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.